Observational studyJournal of neurology2023

Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study.

Fabrizio Vernieri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.